Compare WVE & NUTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WVE | NUTX |
|---|---|---|
| Founded | 2012 | 2011 |
| Country | Singapore | United States |
| Employees | N/A | 944 |
| Industry | Biotechnology: Pharmaceutical Preparations | Retail: Computer Software & Peripheral Equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.1B |
| IPO Year | 2015 | 2009 |
| Metric | WVE | NUTX |
|---|---|---|
| Price | $6.06 | $182.27 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 16 | 2 |
| Target Price | $29.81 | ★ $252.50 |
| AVG Volume (30 Days) | ★ 3.1M | 110.7K |
| Earning Date | 04-28-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 7.93 |
| EPS | N/A | ★ 6.52 |
| Revenue | $3,704,000.00 | ★ $875,257,000.00 |
| Revenue This Year | N/A | $6.12 |
| Revenue Next Year | $85.67 | $4.04 |
| P/E Ratio | ★ N/A | $28.25 |
| Revenue Growth | ★ 149.43 | 82.36 |
| 52 Week Low | $5.02 | $77.21 |
| 52 Week High | $21.73 | $204.00 |
| Indicator | WVE | NUTX |
|---|---|---|
| Relative Strength Index (RSI) | 48.57 | 68.05 |
| Support Level | $6.02 | $90.50 |
| Resistance Level | $6.31 | $192.69 |
| Average True Range (ATR) | 0.32 | 11.19 |
| MACD | 0.07 | 1.26 |
| Stochastic Oscillator | 57.95 | 68.00 |
WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.
Nutex Health Inc is a physician-led, healthcare services and operations company with various hospital facilities in the U.S. states (hospital division), and a primary care-centric, risk-bearing population health management division. The company has three segments: the hospital division, the PHM division, and the real estate division. The hospital division implements and operates health care models, including micro-hospitals, specialty hospitals and hospital outpatient departments (HOPDs). The population health management (PHM) division owns and operates provider networks such as independent physician associations (IPAs). The Real Estate Entities own the land and hospital buildings which are leased to its hospital entities. The majority of the revenue is derived from the Hospital division.